Result Summary for 347414/028
| Protocol ID: | 347414/028 |
| Clinical Study ID: | 347414/028 |
| Official Title: | A randomized, controlled, open, phase-II clinical study to evaluate the safety and immunogenicity of an experimental formulation extemporaneously mixed with SB Bios' Haemophilus influenzae type b (Hib) vaccine, administered as a booster dose with DTPa-HBV-IPV to healthy children 12 to 18 months old. |
| Phase: | Phase 2 |
| Study Indications or Diseases: |
|
| Generic Name: | Combined Diphtheria, Tetanus, Acellular Pertussis Adsorbed, Hepatitis B (Recombinant), Inactivated Polio Vaccine |
| Trade/Product Name: | Pediarix;Infanrix_penta |
| Approved Drug Label: | http://www.gsk.com/products.html |
| Results Summary: |  Click
here to download result summary. |
| Citations: |
|
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.
